ClinConnect ClinConnect Logo
Search / Trial NCT06342557

Transitional ePRO Diary Liver

Launched by FROM- FONDAZIONE PER LA RICERCA OSPEDALE DI BERGAMO- ETS · Mar 26, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called the Transitional EPRO Diary Liver, is part of a larger project aimed at helping patients with liver disease manage their condition more effectively using a digital tool. The main goal of the study is to understand how young patients, aged 14 to 20, transition from pediatric care to adult care after receiving a liver transplant. By gathering information about their experiences, the researchers hope to identify factors that can help improve their psychological well-being during this important change.

Eligible participants are young people who have either received a liver transplant or are waiting for one at a specific transplant center. They should also have used certain mobile apps recently and provide signed consent to join the study. Participants can expect to share their experiences and provide information about their health, which will aid in developing better support tools for both patients and their healthcare teams. It's important to note that while this digital tool will enhance patient care, it is not a replacement for regular medical visits and treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients between the ages of 14 and 20 who have been transplanted at the ASST-PG23 transplant center or are awaiting a liver transplant and belong to the transition to adult services
  • signed informed consent
  • proven use of the APPs (to be assessed based on the last 2 weeks)
  • Exclusion Criteria:
  • -

About From Fondazione Per La Ricerca Ospedale Di Bergamo Ets

Fondazione per la Ricerca Ospedale di Bergamo ETS is a leading clinical research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. Based in Bergamo, Italy, the foundation collaborates with healthcare professionals, academic institutions, and industry partners to design and conduct high-quality clinical trials across various therapeutic areas. With a strong emphasis on ethical standards and patient safety, the foundation aims to facilitate the translation of scientific discoveries into effective treatments, thereby contributing to the enhancement of healthcare practices and the well-being of the community.

Locations

Bergamo, Milano, Italy

Patients applied

0 patients applied

Trial Officials

Stefano Fagiuoli, MD

Principal Investigator

ASST-PG23

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported